| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CCA.2014.02.010 |
| P698 | PubMed publication ID | 24583225 |
| P50 | author | Mustafa Isin | Q84802778 |
| P2093 | author name string | Ugur Gezer | |
| Guven Cetin | |||
| Nejat Dalay | |||
| Nilgun Erten | |||
| Melih Aktan | |||
| Emre Ozgur | |||
| P304 | page(s) | 255-259 | |
| P577 | publication date | 2014-02-26 | |
| P1433 | published in | Clinica Chimica Acta | Q5133740 |
| P1476 | title | Investigation of circulating lncRNAs in B-cell neoplasms | |
| P478 | volume | 431 |
| Q85901412 | A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer |
| Q37276552 | A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer |
| Q37684908 | A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers |
| Q47322610 | Aberrant lncRNA Expression in Multiple Myeloma |
| Q60301539 | Altered expression of lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings |
| Q37009961 | Association of lincRNA-p21 Haplotype with Coronary Artery Disease in a Chinese Han Population |
| Q33761730 | Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma |
| Q26801191 | Circulating RNAs as new biomarkers for detecting pancreatic cancer |
| Q64956903 | Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies. |
| Q26748862 | Circulating long non-coding RNAs in cancer: current status and future perspectives |
| Q33595133 | Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer |
| Q35722266 | Comparison Analysis of Dysregulated LncRNA Profile in Mouse Plasma and Liver after Hepatic Ischemia/Reperfusion Injury |
| Q38905792 | Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. |
| Q41201818 | Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? |
| Q38816315 | Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance |
| Q40349500 | Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease |
| Q36700313 | Genome-wide Long Non-coding RNA Analysis Identified Circulating LncRNAs as Novel Non-invasive Diagnostic Biomarkers for Gynecological Disease |
| Q36547631 | Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer |
| Q52646157 | Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC. |
| Q40056796 | Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
| Q91906527 | LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma |
| Q47673424 | LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2. |
| Q26798205 | LincRNA-p21: Implications in Human Diseases |
| Q26799778 | LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer |
| Q55413676 | LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions. |
| Q58725483 | Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy |
| Q89622527 | Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer |
| Q90578259 | Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer |
| Q92518457 | Long non-coding RNA GAS5 promotes PC12 cells differentiation into Tuj1-positive neuron-like cells and induces cell cycle arrest |
| Q38884574 | Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in GBC-SD/M and GBC-SD gallbladder cancer cell lines |
| Q58800844 | Long non-coding RNA TUG1 promotes the proliferation of colorectal cancer cells through regulating Wnt/β-catenin pathway |
| Q48655385 | Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. |
| Q41694305 | Long non-coding RNAs in B-cell malignancies: a comprehensive overview. |
| Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
| Q60957163 | Long noncoding RNAs as regulators of cancer immunity |
| Q34517905 | MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. |
| Q55245371 | MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. |
| Q64041638 | MicroRNAs and Long Non-coding RNAs in Genetic Diseases |
| Q26801277 | Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA |
| Q35585721 | Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics |
| Q92642131 | Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies |
| Q36640672 | Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications |
| Q47348974 | Panomics for Precision Medicine |
| Q90274839 | Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance |
| Q35394619 | Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics |
| Q38875365 | TUG1: a pivotal oncogenic long non-coding RNA of human cancers |
| Q60960086 | The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response |
| Q89529120 | The Non-Coding RNA Landscape of Plasma Cell Dyscrasias |
| Q26825022 | The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids |
| Q52646451 | The decade of exosomal long RNA species: an emerging cancer antagonist. |
| Q38262017 | The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). |
| Q46316816 | The long noncoding RNA Malat1: Its physiological and pathophysiological functions |
| Q38863697 | The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144 |
| Q33688473 | The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia |
| Q37165105 | The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis |
| Q65001371 | The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer. |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q90394311 | Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets |
| Q64100259 | Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis |
| Q42838399 | Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia |
| Q38950083 | Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma |
Search more.